ANGELIKA BULL: Open Payments
NPI 1801588330 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 46 payments from 16 companies in 2025. Trend: 2023 $595 · 2024 $873 · 2025 $1,300
Food & beverage: $1,300
| Company | Payments | Amount |
|---|---|---|
| Calyxo, Inc. | 2 | $283 |
| UROGEN PHARMA, INC. | 9 | $175 |
| Janssen Biotech, Inc. | 3 | $157 |
| ABBVIE INC. | 5 | $108 |
| Boston Scientific Corporation | 4 | $92 |
| 180 Medical, Inc. | 4 | $92 |
| PFIZER INC. | 5 | $87 |
| TOLMAR, INC. | 3 | $62 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| Ferring Pharmaceuticals Inc. | 1 | $49 |
Products named: CVAC ASPIRATION SYSTEM, RYBREVANT, JELMYTO, XTANDI, LUPRON DEPOT, SpaceOAR VUE System - 10mL, KEYTRUDA, ADSTILADRIN.
Industry payments across NE — which companies pay providers there.
